Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
AIDS and Behavior
Erschienen in: AIDS and Behavior 7/2019

03.01.2019 | Original Paper

Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP)

verfasst von: B. E. Meyerson, P. C. Dinh Jr, J. D. Agley, B. J. Hill, D. N. Motley, G. A. Carter, W. Jayawardene, P. T. Ryder

Erschienen in: AIDS and Behavior | Ausgabe 7/2019

Einloggen, um Zugang zu erhalten

Abstract

To identify factors associated with pharmacist dispensing practice and comfort counseling patients about pre-exposure prophylaxis for HIV prevention (PrEP). Cross-sectional 2016 census of Indiana managing pharmacists measured PrEP awareness, comfort dispensing and counseling patients. Modified Poisson models with robust error variance estimated relative risks and confidence intervals. 15.8% of 284 pharmacists had dispensed PrEP and 11.6% had consulted about it. Dispensing and comfort counseling were associated with confidence in knowledge about PrEP medication adherence and adverse effects of PrEP medication; awareness about PrEP before the survey, number of full time pharmacists in their pharmacy, and increases in new HIV cases from 2015 to 2016 in communities served. Comfort counseling about PrEP was associated with the belief that pharmacists can be an important resource for HIV and HCV treatment.
Literatur
1.
Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.CrossRefPubMedPubMedCentral
2.
3.
4.
Young I, Li J, McDaid L. Awareness and willingness to use HIV pre-exposure prophylaxis amongst gay and bisexual men in Scotland: implications for biomedical HIV prevention. PLoS ONE. 2013;8(5):e64038.CrossRefPubMedPubMedCentral
5.
Jayakumaran JS, Aaron E, Gracely EJ, Schriver E, Szep Z. Knowledge, attitudes, and acceptability of pre-exposure prophylaxis among individuals living with HIV in an urban HIV clinic. PLoS ONE. 2016;11(2):e0145670.CrossRefPubMedPubMedCentral
6.
Strauss BB, Greene GJ, Phillips G, Bhatia R, Madkins K, Parsons JT, Mustanski B. Exploring patterns of awareness and use of HIV pre-exposure prophylaxis among young men who have sex with men. AIDS Behav. 2017;21(5):1288–98.CrossRefPubMedPubMedCentral
7.
Ross I, Mejia C, Melendez J, Chan PA, Nunn AC, Powderly W, Goodenberger K, Liu J, Mayer KH, Patel RR. Awareness and attitudes of pre-exposure prophylaxis for HIV prevention among physicians in Guatemala: implications for country-wide implementation. PLoS ONE. 2017;12(3):e0173057.CrossRefPubMedPubMedCentral
8.
Smith DK, Mendoza MCB, Stryker JE, Rose CE. PrEP awareness and attitudes in a national survey of primary care clinicians in the United States, 2009-2015. PLoS ONE. 2016;11(6):e0156592.CrossRefPubMedPubMedCentral
9.
Calabrese SK, Earnshaw VA, Underhill K, Hansen NB, Dovidio JF. The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access. AIDS Behav. 2014;18(2):226–40.CrossRefPubMedPubMedCentral
10.
11.
12.
Moffat C, Matyanga J. The role of the pharmacist in pre-exposure prophylaxis. Pharmacol Pharm. 2014;5:225–8.CrossRef
13.
Shaeer KM, Sherman EM, Shafiq S, Hardigan P. Exploratory survey of Florida pharmacists’ experience, knowledge and perceptions of HIV pre-exposure prophylaxis. Am J Pharm Assoc. 2014;54(6):610–7.CrossRef
14.
Hammett TM, Phan S, Gaggin J, Case P, Zaller N, Lutnick A, Kral AH, Fedorova EV, Heimer R, Small W, Pollini R, Beletsky L, Latkin C, de Jarlais DC. Pharmacies as providers of expanded health services for people who inject drugs: a review of laws, policies and barriers in six countries. BMC Health Serv Res. 2014;14(261):1–11.
15.
Hogue MD, Grabenstein JD, Foster SL, Rothholz MC. Pharmacist involvement with immunizations: a decade of professional advancement. J Am Pharm Assoc. 2003;2006(46):168–79.
16.
Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS Patient Care STDS. 2012;26:526–31.CrossRefPubMedPubMedCentral
17.
Meyerson BE, Ryder PT, Richey-Smith C. Achieving pharmacy-based public health: a call for public health engagement. Public Health Rep. 2013;128:140–3.CrossRefPubMedPubMedCentral
18.
Bunting BA, Smith BH, Sutherland SE. The Ashville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2003;2008(48):23–31.
19.
Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2003;2006(46):370–7.
20.
21.
Meyerson BE, Davis A, Agley JD, Shannon DJ, Lawrence CA, Ryder PT, Ritchie K, Gassman R. Predicting pharmacy syringe sales to people who inject drugs: policy practice and perceptions 2018. Int J Drug Policy. 2018;56:46–53.CrossRefPubMedPubMedCentral
22.
Meyerson BE, Ryder PT, Von Hippel C, Coy K. We can do more than just sell the test: pharmacist perspectives about over the counter rapid HIV tests. AIDS Behav. 2013;17(6):2109–13.CrossRefPubMed
23.
Ryder PT, Meyerson BE, Coy KC, von Hippel CD. Pharmacists’ perspectives on HIV testing in community pharmacies. J Am Pharm Assoc. 2013;53:595–600.CrossRef
24.
Amesty S, Blaney S, Crawford ND, Rivera AV, Fuller C. Pharmacy staff characteristics associated with support for pharmacy based HIV testing. AIDS Patient Care STDs. 2012;26(9):526–31.CrossRef
25.
Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21(5):1256–67.CrossRefPubMedPubMedCentral
26.
Spector AY, Remien RH, Tross S. PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives. Subst Abuse Treat Prevent Policy. 2015;10(1):1–10.CrossRef
27.
Carter GA, Jayawardene W, Agley J, Garcia J, Miller W, Sherwood-Laughlin, C, Meyerson BE. Development of a 10-item tool to identify APN readiness to prescribe pre-exposure prophylaxis. (in review).
28.
Matyanga CMJ, Khoza S, Gavi S. HIV pre-exposure prophylaxis: pharmacists knowledge, perception and willingness to adopt future implementation in a Zimbabwean urban setting. East Cent Afr J Pharm Sci. 2014;17(1):3–9.
29.
Atkinson J, Sánchez Pozo A, Rekkas D, Volmer D, Hirvonen J, Bozic B, Skowron A, Mircioiu C, Sandulovici R, et al. Hospital and community pharmacists’ perceptions of which competencies are important for their practice. Pharm (Basel). 2016;4(2):21.PubMedCentral
30.
Nash RE, Chalmers L, Stupans I, Brown N. Knowledge, use and perceived relevance of a profession’s Competency Standards; implications for Pharmacy Education. Int J Pharm Pract. 2016;24(6):390–402.CrossRefPubMed
31.
Unni EJ, Lian N, Kuykendall W. Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a mountain west state. J Am Pharm Assoc. 2016;56:527–32.CrossRef
32.
Yoong D, Naccarato M, Sharma M, Wilton J, Senn H, Tan DHS. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis. Int J STD AIDS. 2016;27(8):608–16.CrossRefPubMed
33.
Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893–6.CrossRefPubMed
34.
Balaji AB, Bowles KE, Le BC, Paz-Bailey G. Oster AM for the NHBS Study Group. High HIV incidence and prevalence and associated factors among young MSM, 2008. AIDS. 2013;27(2):269–78.CrossRefPubMedPubMedCentral
35.
Meyerson BE, Agley JD, Davis A, Jayawardene W, Hoss A, Shannon DJ, Ryder PT, Ritchie K, Gassman R. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana. Drug Alcohol Depend. 2016;188:187–92.CrossRef
36.
Agley JD, Meyerson BE, Shannon DJ, Ryder PT, Ritchie K, Gassman R. Using the hybrid method to survey U.S. pharmacists: applying lessons learned to leverage technology. Res Soc Adm Pharm. 2016;13:250–2.CrossRef
37.
38.
39.
Patrick R, Forrest D, Cardenas G, Opoku J, Magnus M, Phillips G, Greenberg A, Metsch L, Kharfen M, et al. Awareness, willingness, and use of pre-exposure prophylaxis among men who have sex with men in Washington, DC and Miami Dade County, FL: National behavioral surveillance, 2011 and 2014. J Acquir Immune Defic Syndr. 2017;75(Supp 3):S375–82.CrossRefPubMedPubMedCentral
40.
Siegler AJ, Mouhanna F, Giler RM, Weiss K, Pembleton E, Guest J, Jones J, Castel A, Yeung H, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28(12):841–9.CrossRefPubMed
41.
Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702–6.CrossRef
42.
Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Boston: Pearson Education; 2013.
43.
Keeter S, Kennedy C, Dimock M, Best J, Craighill P. Gauging the Impact of Growing Nonresponse on Estimates from a National RDD Telephone Survey. Public Opin Q. 2006;70:759–79.CrossRef
44.
Stuart GS, Grimes DA. Social desirability bias in family planning studies: a neglected problem. Contraception. 2009;80(2):108–12.CrossRefPubMed
45.
Blumenthal J, Jain S, Krakower D, Sun X, Young J, Mayer K, Haubrich R. Knowledge is power! Increased provider knowledge scores regarding pre-exposure prophylaxis (PrEP) are associated with higher rates of PrEP prescription and future intent to prescribe PrEP. AIDS Behav. 2015;19(5):802–10.CrossRefPubMedPubMedCentral
46.
Brooks RA, Kaplan RL, Lieber E, Landovitz RJ, Lee SJ, Leibowitz AA. Motivators, concerns and barriers to adoption of pre-exposure prophylaxis for HIV prevention among gay and bisexual men in HIV sero-discordant male relationships. AIDS Care. 2011;23(9):1136–45.CrossRefPubMedPubMedCentral
47.
Bauermeister JA, Meanley S, Pingel E, Soler JH, Harper GW. PrEP awareness and perceived barriers among single young men who have sex with men in the United States. Curr HIV Res. 2013;11(7):520–7.CrossRefPubMedPubMedCentral
48.
Eades CE, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582.CrossRefPubMedPubMedCentral
49.
Anderson C, Blenkinsopp A, Armstrong M. Feedback from community pharmacy users on the contribution of community pharmacy to improving the public’s health: a systemic review of the peer reviewed a non-peer reviewed literature 1990-2002. Health Expect. 2004;7(3):191–202.CrossRefPubMedPubMedCentral
50.
Snella KA, Canales AE, Irons BK, Sleeper-Irons RB, Villarreal MC, Levi-Derrick VE, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006;46:370–7.CrossRef
51.
Potter MB, Gildengorin G, Wang Y, Wu M, Kroon L. Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign. J Am Pharm Assoc. 2010;50:181–7.CrossRef
52.
Letassy N, Dennis V, Lyons TJ, Harrison D, Burton M, Kirkpatrick A. Know your diabetes risk project: student pharmacists educating adults about diabetes risk in a community pharmacy setting. J Am Pharm Assoc. 2010;50:188–94.CrossRef
53.
Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc. 2012;52:507–14.CrossRef
54.
Brown TJ, Todd A, O’Malley C, et al. Community pharmacy-delivered interventions for public health priorities: a systematic review of interventions for alcohol reduction, smoking cessation and weight management, including meta-analysis for smoking cessation. BMJ Open. 2016;6:e009828.CrossRefPubMedPubMedCentral
55.
Hayes Directories, Inc. Hayes Database of Retail Pharmacies. Mission Viejo, California. List published and purchased by authors December 2015.
56.
Metadaten
Titel
Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP)
verfasst von
B. E. Meyerson
P. C. Dinh Jr
J. D. Agley
B. J. Hill
D. N. Motley
G. A. Carter
W. Jayawardene
P. T. Ryder
Publikationsdatum
03.01.2019
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 7/2019
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-02383-7

Weitere Artikel der Ausgabe 7/2019

AIDS and Behavior 7/2019 Zur Ausgabe

Original Paper

Perceived Candidacy for Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men in Paris, France

Original Paper

Disclosure of HIV Serostatus and Pre-exposure Prophylaxis Use on Internet Hookup Sites Among Men Who have Sex with Men

Original Paper

Predictors of PrEP Uptake Among Patients with Equivalent Access

Original Paper

Vulnerable at Each Step in the PMTCT Care Cascade: High Loss to Follow Up During Pregnancy and the Postpartum Period in Tanzania

Original Paper

PrEP in the Real World: Predictors of 6-Month Retention in a Diverse Urban Cohort

Original Paper

Awareness and Perceived Effectiveness of HIV Treatment as Prevention Among Men Who Have Sex with Men in New York City

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise